Moody Aldrich Partners LLC Axonics, Inc. Transaction History

Moody Aldrich Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 27, 2023	SELL	$52.6 - $67.34 $1.06 Million - $1.36 Million	-20,235 Reduced 26.06%	57,427 $3.13 Million
Q4 2022 Jan 23, 2023	SELL	$59.56 - $76.6 $115,248 - $148,221	-1,935 Reduced 2.43%	77,662 $0
Q3 2022 Oct 18, 2022	BUY	$57.96 - $78.12 $1.23 Million - $1.66 Million	21,238 Added 36.39%	79,597 $5.61 Million
Q2 2022 Jul 18, 2022	BUY	$39.5 - $64.42 $2.31 Million - $3.76 Million	58,359 New	58,359 $3.31 Million

233

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.